About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

The Effects of Risperidone and Olanzapine on Thinking

NCT00108368·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

US Department of Veterans Affairs

With

Janssen, LP

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diagnosed with schizophrenia disorder by a DSM IV.
Competent to sign informed consent
No history of poor response to Risperdal and Zyprexa
No organic brain disease

You may not be if

Mental retardation or any chronic medical illness which results in the patient not being appropriate for a switch to Risperdal or Zyprexa.

The record

StatusCompleted

PhasePhase 4

Taking part—

StartedOct 2003

UpdatedJan 21, 2009

Conditions

Schizophrenia Psychotic Disorders

Where1

VA Greater Los Angeles Healthcare System
Los Angeles, California, United States

Clareo Health | The Effects of Risperidone and Olanzapine on Thinking